Table 1. Tumour patients' characteristics.
| Tumour patients | |
|---|---|
| (n = 52) | |
| Epidemiology | |
| Female | 12 (23.1%) |
| Male | 40 (76.9%) |
| Age (years) | 74 (39–92) |
| Body mass index (kg/m2) | 26.1 (17.1–45.3) |
| Concomitant diseases | |
| Diabetes mellitus | 11 (21.2%) |
| Hypertension | 30 (57.7%) |
| Preexisting CKD | 15 (28.8%) |
| Coronary heart disease | 13 (25.0%) |
| Medication on admission | |
| ACE-I./ARB | 17 (32.7%) |
| Diuretics | 12 (23.1%) |
| Urothelial carcinoma | |
| Low grade | 15 (28.8%) |
| High grade | 33 (63.5%) |
| G1 | 7 (13.5%) |
| G2 | 16 (30.8%) |
| G3 | 25 (48.1%) |
| pTa | 30 (57.7%) |
| pT1 | 7 (13.5%) |
| pT2 | 6 (11.5%) |
| pT3a | 1 (1.9%) |
| pT3b | 1 (1.9%) |
| pT4 | 0 (0%) |
| concomitant pCIS | 19 (36.5%) |
| pure pCIS | 2 (3.8%) |
| Renal data | |
| eGFR (ml min per 1.73m2-1) | 71.0 (42.5–89.75) |
| creatinine on admission (mg dl-1) | 0.85 (0.72–1.21) |
CKD, chronic kidney disease; ACE-I./ARB, Angiotensin converting enzyme inhibitor/angiotensin receptor blocker; eGRF, estimated glomerular filtration rate.